NAS:EVGN (Israel)  
Evogene Ltd logo

Evogene Ltd

$ 0.73 -0.0297 (-3.91%) 11:06 AM EST
P/E:
At Loss
P/B:
0.88
Market Cap:
$ 31.52M
Enterprise V:
$ -378.00K
Volume:
29.95K
Avg Vol (2M):
106.38K
Also Trade In:
Volume:
29.95K
Market Cap $:
31.52M
PE Ratio:
At Loss
Avg Vol (2-Month):
106.38K
Enterprise Value $:
-378.00K
PB Ratio:
0.88
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment.
Name Current Vs Industry Vs History
Cash-To-Debt 16.62
Equity-to-Asset 0.65
Debt-to-Equity 0.06
Debt-to-EBITDA -0.07
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -4.91
Distress
Grey
Safe
Beneish M-Score -2.77
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 27.85
9-Day RSI 30.79
14-Day RSI 34.69
6-1 Month Momentum % -23.31
12-1 Month Momentum % -59.04

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.8
Quick Ratio 6.78
Cash Ratio 6.36
Days Inventory 65.36
Days Sales Outstanding 66.21
Days Payable 661.51

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -16.9

Financials (Next Earnings Date:2022-11-17 Est.)

EVGN's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:EVGN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.011
EPS (TTM) ($) -0.78
Beta 1.11
Volatility % 50.18
14-Day RSI 34.69
14-Day ATR ($) 0.07671
20-Day SMA ($) 0.910151
12-1 Month Momentum % -59.04
52-Week Range ($) 0.68 - 2.93
Shares Outstanding (Mil) 41.2

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Evogene Ltd Filings

Document Form Filing Date
No Filing Data

Evogene Ltd Analysis

Share your research

Headlines

See More
No news.